Weed (BUDZ) reported $0 in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Persistent operating losses are financed externally while shrinking assets and rising liabilities reshape the company’s balance-sheet posture.
The cash pattern is not a simple loss-to-cash conversion: FY2023 paired operating cash flow of-$1.07M with a net loss of-$31.6K . By FY2025, operating cash flow was-$195K while net loss widened to-$1.37M , showing that accounting earnings and cash usage can move in opposite directions.
Assets fell from
SG&A rose from
Financial Health Signals
Weed does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Weed scores -223.99, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.4M) relative to total liabilities ($1.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Weed passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Weed reported a net loss of $1.4M while operations used $195K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Weed generated $0 in revenue in fiscal year 2025.
Weed's EBITDA was -$1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 157.2% from the prior year.
Weed reported -$1.4M in net income in fiscal year 2025. This represents a decrease of 168.7% from the prior year.
Weed earned -$0.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 150.0% from the prior year.
Cash & Balance Sheet
Weed held $33K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
BUDZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | N/A | $0 | $0 | $0 | N/A | $0 |
| Cost of Revenue | $0 | $0 | N/A | N/A | $0 | $0 | N/A | N/A |
| Gross Profit | $0 | $0 | N/A | N/A | $0 | $0 | N/A | N/A |
| SG&A Expenses | $75K+10.2% | $68K | N/A | $59K-8.6% | $64K-83.3% | $383K | N/A | $65K |
| Operating Income | -$91K+44.6% | -$164K | N/A | -$67K+28.9% | -$94K+78.4% | -$435K | N/A | -$93K |
| Interest Expense | $13K | N/A | N/A | N/A | $14K+137.3% | $6K | N/A | $3K |
| Income Tax | $0 | $0 | N/A | $33 | $0 | $0 | N/A | $0 |
| Net Income | -$104K+40.6% | -$175K | N/A | -$74K+31.3% | -$108K+75.6% | -$440K-230.6% | -$133K-38.9% | -$96K |
| EPS (Diluted) | $0.00 | $0.00+80.0% | -$0.01-400.0% | $0.000.0% | $0.00+66.7% | $0.00-200.0% | $0.000.0% | $0.00 |
Not reported in any period shown, so not listed: R&D Expenses.
BUDZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $504K-2.3% | $516K-7.9% | $560K+5.2% | $532K-3.0% | $549K-4.6% | $575K-22.1% | $738K+23.7% | $597K |
| Current Assets | $8K-38.3% | $12K-74.1% | $48K+336.3% | $11K-40.8% | $18K-48.2% | $36K-81.2% | $190K+382.2% | $39K |
| Cash & Equivalents | $1K-40.6% | $2K-94.6% | $33K+8182.5% | $400-92.5% | $5K+70.3% | $3K-98.0% | $159K+2900.5% | $5K |
| Total Liabilities | $1.4M+6.6% | $1.4M+8.4% | $1.2M+18.7% | $1.1M+5.5% | $997K+8.2% | $921K-4.0% | $959K+40.0% | $685K |
| Current Liabilities | $1.4M+6.6% | $1.4M+8.4% | $1.2M+18.7% | $1.1M+5.5% | $997K+8.2% | $921K-4.0% | $959K+40.0% | $685K |
| Total Equity | -$939K-12.1% | -$838K-21.7% | -$688K-32.6% | -$519K-15.9% | -$448K-29.4% | -$346K-56.7% | -$221K-150.5% | -$88K |
| Retained Earnings | -$86.6M-0.1% | -$86.5M-0.2% | -$86.3M-0.9% | -$85.5M-0.1% | -$85.5M-0.1% | -$85.3M-0.5% | -$84.9M-0.2% | -$84.8M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
BUDZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$19K+67.6% | -$58K+51.8% | -$120K-2316.5% | -$5K-475.4% | $1K+101.8% | -$72K+43.6% | -$127K-345.2% | -$29K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$29K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Financing Cash Flow | $18K-38.4% | $29K-80.8% | $152K | $0-100.0% | $2K+102.4% | -$84K-130.0% | $281K+1386.6% | $19K |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
BUDZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets | -20.7%+13.3pp | -34.0% | N/A | -13.9%+5.7pp | -19.6%+57.0pp | -76.6%-58.5pp | -18.0%-2.0pp | -16.1% |
| Current Ratio | 0.010.0x | 0.010.0x | 0.040.0x | 0.010.0x | 0.020.0x | 0.04-0.2x | 0.20+0.1x | 0.06 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$688K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Weed Ranks
Frequently Asked Questions
What is Weed's annual revenue?
Weed (BUDZ) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Weed profitable?
No, Weed (BUDZ) reported a net income of -$1.4M in fiscal year 2025.
What is Weed's EBITDA?
Weed (BUDZ) had EBITDA of -$1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Weed's operating cash flow?
Weed (BUDZ) recorded an outflow of $195K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Weed's total assets?
Weed (BUDZ) had $560K in total assets as of fiscal year 2025, including both current and long-term assets.
What is Weed's current ratio?
Weed (BUDZ) had a current ratio of 0.04 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Weed's return on assets (ROA)?
Weed (BUDZ) had a return on assets of -245.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Weed's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Weed (BUDZ) held $33K in cash, cash equivalents and investments, and reported an operating cash outflow of $195K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Weed's debt-to-equity ratio negative or not reported?
Weed (BUDZ) has negative shareholder equity of -$688K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Weed's Altman Z-Score?
Weed (BUDZ) has an Altman Z-Score of -223.99, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Weed's Piotroski F-Score?
Weed (BUDZ) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Weed's earnings high quality?
Weed (BUDZ) reported a net loss of $1.4M while operations used $195K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.